Related Experiment Video
Updated: Jun 19, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
B Morrison1, I Mendoza, D Delgado
1New York University School of Medicine, New York, NY, USA.
Abstract:
American cutaneous leishmaniasis is an important endemic zoonotic disease in the New World that comprises a spectrum of clinical manifestations. Diffuse cutaneous leishmaniasis (DCL) is a rare form of the disease characterized by antigen-specific immunodeficiency that often presents with multiple disfiguring non-ulcerated confluent nodules or plaques that involve large areas of the skin, resembling lepromatous leprosy. Relapse is invariable in advanced stages, despite aggressive chemotherapy, and a plethora of drugs has been tested with unchanging results. We report on a severe an exceptional case that resolved after treatment with amphotericin B, a drug considered only mildly effective, and discuss the therapeutic approach to this disease.
Related Concept Videos
Antiprotozoal Agents
Antifungal Agents
Leishmaniasis
Cryptococcal Meningitis
Candidiasis
